Headline
The latest stories from AHA Today.
The AHA released a new edition of the COVID-19 Snapshot, highlighting the critical needs of hospitals and health systems during the deepening public health emergency.
The Food and Drug Administration issued an emergency use authorization for the first over-the-counter fully at-home diagnostic test for COVID-19. The antigen test for persons age 2 and older can detect the SARS-CoV-2 virus in a nasal swab sample in about 20 minutes.
In an open letter, the AHA, American Medical Association and American Nurses Association thanked health care professionals for their dedication and sacrifices this year and urged them to continue their battle against COVID-19 by taking a vaccine and sharing their experience with others.
Ahead of a Dec. 17 meeting of its Vaccines and Related Biological Products Advisory Committee, the Food and Drug Administration released a briefing document confirming Moderna鈥檚 data on the safety and efficacy of the mRNA-1273 COVID-19 vaccine candidate.
A bipartisan group of senators and representatives released legislative text for both the Emergency Coronavirus Relief Act of 2020, a $748 billion COVID-19 relief package that boosts funding for health care providers, vaccines and testing, and the Bipartisan State and Local Support and Small鈥
The Cybersecurity and Infrastructure Security Agency and Health Sector Cybersecurity Coordination Center are alerting organizations to a global cyberattack using a hidden back door or 鈥渢rojanized鈥 legitimate updates to the SolarWinds Orion performance monitoring platform to access public and鈥
The AHA, joined by four other national hospital groups and hospital pharmacists representing participants in the 340B drug pricing program, filed a federal lawsuit against the Department of Health and Human Services over the department鈥檚 failure to enforce program requirements and halt drug company鈥
AHA commented on the No Surprises Act, bipartisan, bicameral legislation released Friday to address surprise medical bills.
In this three-part series, Parkland Health and Hospital System in Dallas shares its most successful tools and approaches to help spot and reduce risk factors for suicide.
Combining the anti-inflammatory drug baricitinib with the antiviral drug remdesivir reduced the median recovery time for hospitalized COVID-19 patients from eight to seven days, according to clinical trial results published in the New England Journal of Medicine.